Market Overview

Cantor Fitzgerald Downgrades Tonix Pharmaceuticals to Speculative Buy

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TNXP

DateFirmActionFromTo
Aug 2017Roth CapitalUpgradesNeutralBuy
Sep 2016Cantor FitzgeraldDowngradesBuyHold
Sep 2016Roth CapitalDowngradesBuyNeutral

View More Analyst Ratings for TNXP
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TNXP)